Page last updated: 2024-12-06

nickel nitrilotriacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID56840863
MeSH IDM0233754

Synonyms (8)

Synonym
nickelate(1-), (n,n-bis((carboxy-kappao)methyl)glycinato(3-)-kappan,kappao)-, hydrogen, (t-4)-
hydrogen (n,n-bis(carboxymethyl)glycinato(3-)-n,o,o',o'')nickelate(1-)
einecs 252-235-5
nickel nitrilotriacetic acid
nickelate(1-), (n,n-bis((carboxy-kappao)methyl)glycinato(3-)-kappan,kappao)-, hydrogen (1:1), (t-4)-
hsdb 1309
unii-810w6qz3qt
2-[bis(carboxylatomethyl)amino]acetate;hydron;nickel(3+)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"In targeted photodynamic therapy (tPDT), photosensitizers (PS) are targeted to disease tissue to reduce the dosage of PS and in addition to reduce the photo damage to the non-target tissue."( Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles.
Irudayaraj, J; Manorama, SV; Narsireddy, A; Rao, NM; Vijayashree, K, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's21 (20.39)18.2507
2000's40 (38.83)29.6817
2010's39 (37.86)24.3611
2020's3 (2.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.96%)5.53%
Reviews1 (0.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other102 (98.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]